Man Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Man Group’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-26,323	Closed	-$705K	–	2083
2019 Q1	$705K	Sell	26,323 -6,496	-20%	-$165K	﹤0.01%	1660
2018 Q4	$742K	Sell	32,819 -11,402	-26%	-$446K	﹤0.01%	1543
2018 Q3	$2.44M	Buy	44,221 +7,335	+20%	+$468K	0.01%	1339
2018 Q2	$2.63M	Sell	36,886 -46,831	-56%	-$3.31M	0.01%	1255
2018 Q1	$5.14M	Buy	+83,717	New	+$7.35M	0.02%	828

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Man Group's TTPH Position: Q2 2019 in Review

Man Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 26,323 shares — an estimated $705K sold.

Man Group first reported a position in TTPH in Q1 2018 and held it in 5 quarters. The position peaked at $5.14M in Q1 2018. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

Man Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Man Group sold 26,323 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $705K.
Man Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2018 and held it in 5 quarters.
Man Group's Tetraphase Pharmaceuticals, Inc. position peaked at $5.14M in Q1 2018.
66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Man Group's 13F filing for Q2 2019, filed 14 Aug 2019.